RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lucira Health - Stock

Lucira Health ROA 2024

Lucira Health ROA

-0.27

Ticker

LHDXQ

ISIN

US54948U1051

In 2024, Lucira Health's return on assets (ROA) was -0.27, a 0% increase from the 0 ROA in the previous year.

Lucira Health Aktienanalyse

What does Lucira Health do?

Lucira Health is an American company specializing in the development and manufacturing of diagnostic devices and kits. It was founded in 2013 and is headquartered in Emeryville, California. The company was founded by Dr. Erik Engelson and Dr. Jessie Zhou, both of whom have experience in developing molecular diagnostic tests. Lucira Health initially provided research and development services for other companies before deciding to develop its own products. In 2018, the company won first place in the XPRIZE Rapid-Response COVID-19 competition and received a $5 million award for the development of a rapid COVID-19 test. Lucira Health's business model focuses on the development and manufacturing of diagnostic devices and kits. The company works closely with other organizations to develop faster, more effective, and cost-efficient tests. It also utilizes partnerships and licensing agreements to market its devices and tests. Lucira Health has two main divisions: molecular diagnostics and point-of-care diagnostics. In molecular diagnostics, the company offers a range of tests specifically designed for molecular diagnostics, including tests for diagnosing infectious diseases such as COVID-19, influenza, and hepatitis B and C. In point-of-care diagnostics, Lucira Health specializes in the development of point-of-care diagnostic devices that are designed to deliver fast and accurate test results within minutes. The company has developed the first FDA-approved COVID-19 test kit that can be used at home. The test kit provides results within 30 minutes and requires only a nasal swab. In addition to its diagnostic products, the company has also developed a platform that allows users to submit and track their test results online. In conclusion, Lucira Health is a company focused on the development of diagnostic devices and kits. With its emphasis on molecular and point-of-care diagnostics, the company has developed a range of tests that can be used to diagnose infectious diseases. With its history of collaboration with other organizations and the $5 million award from the XPRIZE Rapid-Response COVID-19 competition, Lucira Health is expected to continue developing innovative products that contribute to the improvement of public health. Lucira Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Lucira Health's Return on Assets (ROA)

Lucira Health's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Lucira Health's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Lucira Health's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Lucira Health’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Lucira Health stock

What is the Return on Assets (ROA) of Lucira Health this year?

The Return on Assets (ROA) of Lucira Health is -0.27 undefined this year.

What was the ROA of Lucira Health compared to the previous year?

The ROA of Lucira Health has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Lucira Health?

A high ROA is advantageous for investors of Lucira Health, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Lucira Health?

A low ROA can be unfavorable for investors of Lucira Health as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Lucira Health affect the company?

An increase in ROA of Lucira Health can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Lucira Health impact the company?

A reduction in the ROA of Lucira Health can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Lucira Health?

Some factors that can influence the ROA of Lucira Health include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Lucira Health important for investors?

The ROA of Lucira Health is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Lucira Health take to improve ROA?

To improve ROA, Lucira Health can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Lucira Health pay?

Over the past 12 months, Lucira Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lucira Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Lucira Health?

The current dividend yield of Lucira Health is .

When does Lucira Health pay dividends?

Lucira Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lucira Health?

Lucira Health paid dividends every year for the past 0 years.

What is the dividend of Lucira Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lucira Health located?

Lucira Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lucira Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lucira Health from 7/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did Lucira Health pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Lucira Health in the year 2023?

In the year 2023, Lucira Health distributed 0 USD as dividends.

In which currency does Lucira Health pay out the dividend?

The dividends of Lucira Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lucira Health

Our stock analysis for Lucira Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lucira Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.